Medication persistence and the use of generic and brand-name blood pressure-lowering agents

Giovanni Corrao; Davide Soranna; Carlo La Vecchia; Alberico L. Catapano; Enrico Agabiti‐Rosei; Gianfranco Gensini; Luca Merlino; Giuseppe Mancia

doi:10.1097/hjh.0000000000000130

Abstract

1 min read

Generic products are not responsible for the high rate of discontinuation from antihypertensive drug therapy. Assuming therapeutic equivalence, clinical implication is of prescribing generic drug therapies.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2016

Registered Randomized Trials Comparing Generic and Brand-Name Drugs: A Survey

Maria Elena Flacco, Lamberto Manzoli, Stefania Boccia, Anna Puggina, Annalisa Rosso, Carolina Marzuillo, Giacomo Scaioli, Maria Rosaria Gualano, Walter Ricciardi, Paolo Villari, John P A Ioannidis

Article2004

Ambulatory blood pressure pattern in patients with resistant hypertension as a function of the circadian time of antihypertensive therapy

Ramon C Hermida

Article2004

Administration time-dependent effects on ambulatory blood pressure of doxazosin gits as added therapy in uncontrolled hypertensive patients

Ramon C Hermida

Article2018

A real-world comparison of drug discontinuation rates between clinical trial eligible and ineligible patients in the British Association of Dermatologists Biologic Interventions Register (BADBIR).

K.J. Mason, Juliet N. Barker, Kay Hogan Smith, Philip Hampton, Mark Lunt, Kathleen McElhone, Richard Warren, Zenas Z N Yiu, Christopher Em Griffiths, A. David Burden

Article2009

Impact of Biological Agents and Tissue Engineering Approaches on the Treatment of Rheumatic Diseases

Marta Alves da Silva, Albino Martins, Ana A. Teixeira, Rui L Reis, Nuno M. Neves